Latest news
Loading news…
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Ajax Therapeutics was acquired by Eli Lilly in 2026 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
Key People at Ajax Therapeutics
Senior Vice President and Head of Chemistry, Manufacturing and Controls
Chief Medical Officer
CEO and Co-founder
2
professional contacts at Ajax Therapeutics
Contact execs at Ajax Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ajax Therapeutics
Loading news…
FAQs about Ajax Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.